Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6224 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

New AI-powered tool could enhance forensic investigations of traumatic brain injuries

A study led by University of Oxford researchers has developed an advanced physics-based AI-driven tool to aid traumatic brain injury (TBI) investigations in forensics and law enforcement. The findings have been published today in Communications Engineering.

Anticholinergic medications given to people with psychosis could worsen memory

Medications routinely given to people experiencing psychosis could be worsening some of their cognitive function, including memory and concentration, according to a new analysis of existing research.

Study provides support for WHO guidelines for treating pregnant women with HIV

A new analysis by researchers at Oxford Population Health’s Infectious Disease Epidemiology Unit has provided robust evidence in support of current World Health Organization (WHO) guidelines for treating pregnant women living with HIV. The study is published in Clinical Microbiology and Infection.

Junk food ads flood children’s social media feeds, new study finds

New research shows children and young people are bombarded with social media ads for junk food, which influence their food choices, but current rules do little to protect them.

Study finds previously unidentified genetic determinants of rare disease

A landmark study involving Oxford researchers has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.

IOI awards £5m to Oxford consortium to develop new therapies for drug-resistant tuberculosis

The award to a group of 17 interdisciplinary researchers from Oxford University will allow them to develop new therapies for drug-resistant tuberculosis.

Bangladesh malaria vaccine and drug administration trial begins

After more than a year of community engagement and preparation in 100 villages with over 12,000 inhabitants across the Chittagong Hill Tracts, a mass malaria vaccine (R21/Matrix M) and drug administration (DHA, piperaquine, and single low dose primaquine) study was launched on 15 February.

New study on how positive psychology interventions can benefit incarcerated people

Max Klapow and colleagues have conducted the first-ever empirical evaluation of positive psychology interventions (PPIs) in prison settings.

At-home test could play key role in type-1 diabetes screening

A new home test to diagnose type-1 diabetes (T1D) is being investigated in a major UK study led by researchers at the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre.

Lifestyle and environmental factors affect health and ageing more than our genes

A new study led by researchers from Oxford Population Health has shown that a range of environmental factors, including lifestyle (smoking and physical activity) and living conditions, have a greater impact on health and premature death than our genes.

Novel AI tool studies cellular interactions in human brain tissues

Dr David A Menassa is one of the senior authors on a new paper in Nature Communications that reports on the use of DeepCellMap - an adaptable open-source deep learning tool which studies cellular interactions in human brain tissues in an automated way.

Major investment to transform mental health treatment research and further develop secure NHS data platform

Department researchers awarded £17 million from Wellcome to analyse NHS talking therapy outcomes and enhance secure data research. The project will enable unprecedented mental health treatment research through the OpenSAFELY platform.

March 2025 - Volunteer opportunities

Bodleian Libraries Update - Feb 2025 - REF 2029 | Book Club | Training sessions |OPEN | Wellbeing Week in the Radcliffe Science Library

Sixty Seconds with Mark Walker, Director of MSD IT Services

New MSD IT Services Director Mark Walker talks to us about supporting world class research, why invisibility is a positive thing, and the joy of unexpectedly discovering DJing.

Oxford Researchers Uncover a Key Mechanical Signalling Pathway Linked to Neurological Disorders

A team of researchers at the Department of Oncology have uncovered a key mechanism by which cells respond to their physical environment. In a pioneering study, published in Science Advances, Eric O’Neill and his team describe a new signalling cascade, through which mechanical forces trigger the assembly of nuclear actin, crucial for nuclear integrity.

Innovation at the MRC WIMM

Here at the MRC Weatherall Institute of Molecular Medicine, we foster a strong culture of innovation.

Oxford biologists and engineers awarded £2 million to grow human neurons as brain circuits in chambers made of oil

The circuits of the brain linking together the regions known as the midbrain, the striatum and the cortex are critical to understanding disorders such as Parkinson’s disease, addiction and autism. Understanding and modelling how the circuit works in human neurons has been difficult, mainly due to the inaccessibility of the human brain and the limitations of current technologies to reliably grow circuits of human neurons in the laboratory.

British and Japanese young people make mental health recommendations for public health emergencies

Twenty eight young people from the UK and Japan played a leading role in co-designing the research, interviewing other young people and adults, analysing the findings, and developing the recommendations for policy makers.

New partnership to advance public health and life science research collaboration in West Africa

The Pandemic Sciences Institute, including principal investigators from the Oxford Vaccine Group, has signed a memorandum of understanding with Institut Pasteur de Dakar (IPD) to become a partner institution. PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.

Load More